DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China flag China · Delayed Price · Currency is CNY
20.74
-0.08 (-0.38%)
Nov 18, 2026, 2:55 PM CST

SHA:603233 Revenue

DaShenLin Pharmaceutical Group had revenue of 7.32B CNY in the quarter ending September 30, 2026, with 11.78% growth. This brings the company's total for the last twelve months to 28.74B, up 7.11% year-over-year. In the year 2025, DaShenLin Pharmaceutical Group had annual revenue of 27.50B with 3.80% growth. That makes DaShenLin Pharmaceutical Group the 2,940th largest company in the world by revenue and 342nd in China.

Revenue (ttm)
28.74B
Revenue Growth
+7.11%
P/S Ratio
0.82
Revenue / Employee
698.62K
Employees
41,141
Market Cap
23.62B

Revenue Chart

Revenue by Segment

  • Retail 22.35B 81.4%
  • Franchise and Distribution 4.48B 16.3%
  • Other Operations 635.01M 2.3%
Fiscal year ended Dec 31, 2025 See the full SHA:603233 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202527.50B1.01B3.80%
Dec 31, 202426.50B1.97B8.01%
Dec 31, 202324.53B3.28B15.45%
Dec 31, 202221.25B4.49B26.78%
Dec 31, 202116.76B2.18B14.92%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.